AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

March 3, 2022

Period of Report

February 10, 2022

Accession Number

0001062993-22-006643